急性与慢性移植物抗宿主病之间的关联
该日本登记研究以allo-HCT后100天为界标,分析14 618例骨髓/外周血和6135例脐血移植患者急性GVHD对慢性GVHD的影响。骨髓/外周血队列中,需全身激素治疗的慢性GVHD风险随急性GVHD 0至2级逐级升高,但2级与3-4级间相似;脐血队列结果一致。严重慢性GVHD风险随急性GVHD每增一级而升高,2级与3-4级间亦如此。
要点
- 骨髓/外周血移植中,需全身激素的慢性GVHD风险随急性GVHD 0至2级逐级升高,2级与3-4级间相似。
- 脐血移植队列中,上述需全身激素慢性GVHD风险模式得到重复验证。
- 严重慢性GVHD风险随急性GVHD分级每增一级而升高,包括2级与3-4级之间。
核心结论
- 既往急性GVHD的等级特征有助于对慢性GVHD及其严重程度进行风险分层,可能有助于制定风险适应的抢先治疗策略。
研究设计与样本
- 基于日本登记数据的分析,界标点设为allo-HCT后100天,排除界标点前死亡或复发患者。
- 分析骨髓或外周血移植患者14 618例,脐血移植患者6135例。
主要发现
- 骨髓/外周血队列中,需全身激素治疗的慢性GVHD风险:急性GVHD 0级 vs 1级 HR 1.32(95%CI 1.19-1.46,P<.001);1级 vs 2级 HR 1.41(95%CI 1.28-1.56,P<.001)。
- 骨髓/外周血队列中,需全身激素治疗的慢性GVHD风险:急性GVHD 2级 vs 3-4级 HR 1.02(95%CI 0.91-1.15,P=1.0),未达统计学显著。
- 脐血队列中上述需全身激素慢性GVHD风险模式得到重复验证。
- 严重慢性GVHD风险随急性GVHD分级每增一级而升高:急性GVHD 2级 vs 3-4级 HR 1.70(95%CI 1.12-2.58,P=.025)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic graft-versus-host disease (GVHD) is 1 of the major complications after allogeneic hematopoietic cell transplantation (allo-HCT). Although various risk factors for chronic GVHD have been reported, limited data are available regarding the impact of acute GVHD on chronic GVHD. We examined the association between acute and chronic GVHD using a Japanese registry data set. The landmark point was set at day 100 after allo-HCT, and patients who died or relapsed before the landmark point were excluded. In total, 14 618 and 6135 patients who underwent allo-HCT with bone marrow or peripheral blood (BM/PB) and with umbilical cord blood (UCB), respectively, were analyzed. In the BM/PB cohort, the risk for chronic GVHD that requires systemic steroids increased with each increase in acute GVHD grade from 0 to 2 (grade 0 vs 1 [hazard ratio (HR), 1.32; 95% confidence interval (CI), 1.19-1.46; P < .001]; grade 1 vs 2 [HR, 1.41; 95% CI, 1.28-1.56; P < .001]), but the risk was similar between acute GVHD grade 2 and grade 3 to 4 (HR, 1.02; 95% CI, 0.91-1.15; P = 1.0). These findings were confirmed in the UCB cohort. We further observed that the risk for severe chronic GVHD increased with each increment in the grade of acute GVHD, even between acute GVHD grade 2 and grade 3 to (grade 2 vs 3-4: HR, 1.70; 95% CI, 1.12-2.58; P = .025). In conclusion, the preceding profiles of acute GVHD should help to stratify the risk for chronic GVHD and its severity, which might be useful for the development of risk-adopted preemptive strategies for chronic GVHD.
引用
- Tamaki M, Akahoshi Y, Inamoto Y, et al. Associations between acute and chronic graft-versus-host disease. Blood Adv. 2024. PMID: 38985337. doi:10.1182/bloodadvances.2024013442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。